Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 1,244 | 1,436 | 2,534 | 6,892 | 1,039 |
| Gross Profit | 1,244 | 1,436 | 2,534 | 6,892 | 1,039 |
| Operating Expenses | 23,290 | 19,841 | 62,783 | 19,789 | 20,524 |
| Operating Income | -22,046 | -18,405 | -60,249 | -12,897 | -19,485 |
| Interest Expense | 0 | 104 | 75 | 76 | 68 |
| Other Income | 25,137 | 1,080 | 73 | 1,373 | 1,298 |
| Pre-tax Income | 3,091 | -17,429 | -60,251 | -11,600 | -18,255 |
| Net Income Continuous | 3,091 | -17,429 | -35,931 | -11,600 | -18,255 |
| Net Income | $3,091 | $-17,429 | $-35,931 | $-11,600 | $-18,255 |
| EPS Basic Total Ops | 0.01 | -0.36 | -0.68 | -0.21 | -0.33 |
| EPS Basic Continuous Ops | 0.06 | -0.32 | -0.65 | -0.21 | -0.33 |
| EPS Diluted Total Ops | 0.01 | -0.36 | -0.68 | -0.21 | -0.33 |
| EPS Diluted Continuous Ops | 0.05 | -0.32 | -0.65 | -0.21 | -0.33 |
| EBITDA(a) | $-21,468 | $-17,803 | $-18,831 | $-12,304 | $-19,005 |